Teradata Corporation Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Teradata Corporation Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Teradata Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Teradata Corporation Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| TDC | VIR | |
|---|---|---|
Market Cap | $2.83B | $1.80B |
Volume | 1,343,944 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $37.88 | $11.78 |
52-Week Low | $20.71 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.52B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →